Pharmacodynamics of ceftriaxone for the treatment of methicillin‐susceptible Staphylococcus aureus: is it a viable treatment option?
Aaron J. Heffernan, Fekade B. Sime, Sazlyna Mohd Sazlly Lim, Santosh Adiraju, Steven C. Wallis, Jeffrey Lipman, Gary Grant, Jason A. Roberts
Topics & Concepts
CeftriaxoneDosingCephalosporinStaphylococcus aureusPharmacodynamicsMedicineMinimum inhibitory concentrationAntibioticsAntibacterial agentMicrobiologyPharmacologyPharmacokineticsBiologyBacteriaGeneticsAntimicrobial Resistance in StaphylococcusAntibiotics Pharmacokinetics and EfficacyAntibiotic Resistance in Bacteria